Loading data for IHE — first visit, this takes a few seconds.
iShares U.S. Pharmaceuticals ETF (IHE)
NYSEArca: IHE
· Real-Time Price · USD
105.42
+1.78 (1.72%)
At close: Sep 03, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
iShares U.S. Pharmaceuticals ETF (IHE) Stock Price, Analysis & Data
No data available
| Bid | 0 |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| 0.00 | |
| n/a | |
| 27.45 | |
| n/a | |
| P/B (ttm) | 0.00 |
| P/S (ttm) | 0.00 |
| Earnings Date | n/a |
| Ask | 165.32 |
| Volume | 89,983 |
| Avg. Volume (20D) | 258,595 |
| Open | 104.78 |
| Previous Close | 103.64 |
| Day's Range | 103.66 - 105.00 |
| 52-Week Range | 69.02 - 108.66 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About IHE
The underlying index includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines. The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The fund is non-diversified....
Industry n/a
Sector n/a
IPO Date May 5, 2006
Employees n/a
Stock Exchange NYSEArca
Ticker Symbol IHE
Financial Performance
In undefined, iShares U.S. Pharmaceuticals ETF's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial StatementsEarnings Surprise
iShares U.S. Pharmaceuticals ETF has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
Page 1 of 2